Skip to main content

Trexquant Investment LP

Position in BSX — Boston Scientific Corp

CIK 1633445 STAMFORD, CT

Position in BSX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$24,189,560
-$6,164,731 QoQ
Shares Held
385,491
+21.1% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 91.128197545468.ToString("F0")% Shared 0.ToString("F0")% None 8.871802454532013.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Mar 31, 2026
CallValue
$432,975
CallShares
6,900
PutValue
$533,375
PutShares
8,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $264,507,021 across 41 Medical Devices names. BSX ranks #3 (9.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BSX
Boston Scientific Corp
This page
385,491 $24,189,560

All Filings in BSX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,189,560 385,491
2026-03-31 $432,975 6,900
2026-03-31 $533,375 8,500
2025-12-31 $30,354,291 318,346
2025-09-30 $42,202,715 432,272
2025-06-30 $11,793,940 109,803
2025-03-31 $2,463,691 24,422
2024-09-30 $1,771,029 21,134
2023-12-31 $11,875,041 205,415
2023-09-30 $4,165,286 78,888
2023-06-30 $22,378,763 413,732
2023-03-31 $4,769,009 95,323
2022-06-30 $1,375,523 36,907
2021-06-30 $4,851,036 113,448
2020-12-31 $2,047,963 56,967
2020-09-30 $10,697,959 279,978
2020-06-30 $3,433,863 97,803
2020-03-31 $1,760,584 53,956